countryUnited StatesUnited KingdomAfghanistanAlbaniaAlgeriaAmerican SamoaAndorraAngolaAnguillaAntarcticaAntigua and BarbudaArgentinaArmeniaArubaAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBermudaBhutanBoliviaBosnia and HerzegovinaBotswanaBouvet IslandBrazilBritish Indian Ocean TerritoryBrunei DarussalamBulgariaBurkina FasoBurundiCambodiaCameroonCanadaCape VerdeCayman IslandsCentral African RepublicChadChileChinaChristmas IslandCocos (Keeling) IslandsColombiaComorosCongoCongo, The Democratic Republic of TheCook IslandsCosta RicaCote D'ivoireCroatiaCubaCyprusCzech RepublicDenmarkDjiboutiDominicaDominican RepublicEcuadorEgyptEl SalvadorEquatorial GuineaEritreaEstoniaEthiopiaFalkland Islands (Malvinas)Faroe IslandsFijiFinlandFranceFrench GuianaFrench PolynesiaFrench Southern TerritoriesGabonGambiaGeorgiaGermanyGhanaGibraltarGreeceGreenlandGrenadaGuadeloupeGuamGuatemalaGuineaGuinea-bissauGuyanaHaitiHeard Island and Mcdonald IslandsHoly See (Vatican City State)HondurasHong KongHungaryIcelandIndiaIndonesiaIran, Islamic Republic ofIraqIrelandIsraelItalyJamaicaJapanJordanKazakhstanKenyaKiribatiKorea, Democratic People's Republic ofKorea, Republic ofKuwaitKyrgyzstanLao People's Democratic RepublicLatviaLebanonLesothoLiberiaLibyan Arab JamahiriyaLiechtensteinLithuaniaLuxembourgMacaoMacedonia, The Former Yugoslav Republic ofMadagascarMalawiMalaysiaMaldivesMaliMaltaMarshall IslandsMartiniqueMauritaniaMauritiusMayotteMexicoMicronesia, Federated States ofMoldova, Republic ofMonacoMongoliaMontserratMoroccoMozambiqueMyanmarNamibiaNauruNepalNetherlandsNetherlands AntillesNew CaledoniaNew ZealandNicaraguaNigerNigeriaNiueNorfolk IslandNorthern Mariana IslandsNorwayOmanPakistanPalauPalestinian Territory, OccupiedPanamaPapua New GuineaParaguayPeruPhilippinesPitcairnPolandPortugalPuerto RicoQatarReunionRomaniaRussian FederationRwandaSaint HelenaSaint Kitts and NevisSaint LuciaSaint Pierre and MiquelonSaint Vincent and The GrenadinesSamoaSan MarinoSao Tome and PrincipeSaudi ArabiaSenegalSerbia and MontenegroSeychellesSierra LeoneSingaporeSlovakiaSloveniaSolomon IslandsSomaliaSouth AfricaSouth Georgia and The South Sandwich IslandsSpainSri LankaSudanSurinameSvalbard and Jan MayenSwazilandSwedenSwitzerlandSyrian Arab RepublicTaiwan, Province of ChinaTajikistanTanzania, United Republic ofThailandTimor-lesteTogoTokelauTongaTrinidad and TobagoTunisiaTurkeyTurkmenistanTurks and Caicos IslandsTuvaluUgandaUkraineUnited Arab EmiratesUnited KingdomUnited StatesUnited States Minor Outlying IslandsUruguayUzbekistanVanuatuVenezuelaViet NamVirgin Islands, BritishVirgin Islands, U.S.Wallis and FutunaWestern SaharaYemenZambiaZimbabwe
select categoryAnimal Health Care (International)Animal Health Care (India - Cattle)Animal Health Care (India - Poultry/Aqua/Swine)Human Health CareResearch & DevelopmentPurchase & LogisticsOthers & Resume
How did you hear about us?
How did you hear about usNR Business TeamGoogle SearchInternational MagazineEngormix.comE-feedlink.comFeed Navigator EmailInternational ExhibitionAny Other Source
Get the best in class natural solutions for Animal and Human care anywhere in the world
Standardized/custom programs of preclinical discovery solutions to meet the needs of the Pharmaceutical, Natural Product and Biotechnology Industries. Biochemical/Enzyme inhibition assays are biological methods through which the bioactivity of test substances can be assessed.
In the preclinical discovery market, the versatility of enzyme-based assays, a lesser turnaround time and low costs influence most companies to choose enzyme based assays over others. This unit has standardized and routinely perform more than 70 validated in-vitro assays targeting various therapeutic areas using specialized assay technologies based on different detection models like absorbance (Colorimetric, ELISA), Luminescence and Fluorescence (Fluorescence Intensity, Fluorescence Polarization, Time-Resolved Fluorescence) in 96 and 384 well formats. We provide a spectrum of these services in cellular assays that are designed to accelerate the pace and increase the productivity of discovery and development programs.
Screening and assay development remains one of the most challenging and resource-intensive steps in the drug discovery process, with the end result depending on the proper balance of assays, experimental design, and data management. Natural Remedies provides a broad spectrum of high-quality service to support various stages of drug discovery and development.
With state-of-the-art facilities and instrumentation, we offer services in assay development, compound profiling and in vitro safety. Natural Remedies uses a number of primary and immortalized cell lines to assay test compounds. We are committed to providing high quality, cost-effective in vitro services with a rapid turnaround time.
Using these in vitro cell based assays, compounds can be rapidly and cost effectively screened for activity prior to more expensive and time-consuming in vivo analysis.
Safety assessment is an important criterion for compound development before expensive preclinical and clinical studies. In order to predict Genotoxicity or specific cellular impacts, Natural Remedies provides GLP/Non-GLP in vitro genetic testing as per OECD guidelines (Mouse Lymphoma, Ames, Chromosome Aberration, Micronucleus, Steroidogenesis Assay, in-vitro Skin corrosion, Eye Irritation, Skin irritation). All work is carried out under well-defined standard operating procedures (SOPs) by highly qualified scientists.
As researchers try to predict the absorption, distribution, metabolism and excretion (ADME) characteristics of a compound, the advent of various in-vitro high throughput assays has come as a boon. The liver is the central organ in ADME. It is responsible for most of the metabolic processes involving the breakdown of drugs and their excretion from the body. The cytochrome P450 superfamily of enzymes sits at the crossroads of liver metabolism, encompassing dozens of gene products that catalyze the breakdown of drugs and toxins. We at Natural Remedies have standardized several Cytochrome P450 assays that are useful for studying interaction as well as metabolism. In addition, we have standardized various in-vitro permeability models like PAMPA and Caco-2 monolayer permeability assay that are useful for absorption studies.
We are a leading group in the field of phytochemistry in India. Our dedicated team of phytochemists is involved in isolating bioactive phytochemicals from different medicinal plants. We have been supplying phytochemical reference substances over a decade now. Our customers include herbal companies, national laboratories, Pharmacopoeia bodies, universities and other governmental and non-governmental organizations involved in herbal research.
Currently, we offer more than 200 phytochemical reference substances and we are in the process of isolating many more phytochemicals from different medicinal plants. Our strength lies in quality and reliability of our products and services. Our passion for phytocompounds is driving us to do more in this area and we solicit your active participation in this endeavour. For more details please visit www.phytocompounds.com